Urigen Pharmaceuticals is a global leader in non-oncological urology treatments. As the baby boomer population ages there is a growing patient population. We specialize in developing innovative products to ameliorate the cause and symptoms associated with urological ailments, specifically Interstitial Cystitis/Bladder Pain Syndrome (“BPS” or “IC/BPS”)
View Top Employees from Urigen Pharmaceuticals, Inc.| Website | http://www.urigen.com |
| Revenue | $7.2 million |
| Employees | 3 (2 on RocketReach) |
| Founded | 1997 |
| Address | 305 E High St Ste 7, Bound Brook, New Jersey 08805, US |
| Phone | (732) 369-5911 |
| Fax | (732) 356-1125 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Pharmaceuticals, Manufacturing, Science and Engineering, Drug Discovery, Medical, Health Care, Pharmaceutical |
| Competitors | Cytochroma Inc., Presidio Pharmaceuticals, Inc., QRxPharma, TARIS Bio |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 541710 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Urigen Pharmaceuticals, Inc. employee's phone or email?
Urigen Pharmaceuticals, Inc. Questions
The Urigen Pharmaceuticals, Inc. annual revenue was $7.2 million in 2024.
Christopher Meenan is the Vice President Commercial and Product Development of Urigen Pharmaceuticals, Inc..
2 people are employed at Urigen Pharmaceuticals, Inc..
Urigen Pharmaceuticals, Inc. is based in Bound Brook, New Jersey.
The NAICS codes for Urigen Pharmaceuticals, Inc. are [325414, 32, 3254, 54, 325, 541710, 541, 32541, 54171, 5417].
The SIC codes for Urigen Pharmaceuticals, Inc. are [283, 28].
Top Urigen Pharmaceuticals, Inc. Employees
Related Companies
